Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 47Lung Neoplasms 23Carcinoma, Hepatocellular 23Small Cell Lung Carcinoma 16Cholangiocarcinoma 10Breast Neoplasms 10Urinary Bladder Neoplasms 9Biliary Tract Neoplasms 9Neoplasms 8Neoplasm Metastasis 8Liver Neoplasms 8Pancreatic Neoplasms 6Carcinoma 6Endometrial Neoplasms 5Triple Negative Breast Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Gallbladder Neoplasms 4Carcinoma, Transitional Cell 4Ovarian Neoplasms 3Neoplasms by Site 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Bile Duct Neoplasms 3Adenocarcinoma 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Respiratory Tract Neoplasms 2Pathologic Complete Response 2Oropharyngeal Neoplasms 2Neoplasms by Histologic Type 2

Interventions

Cisplatin 11pembrolizumab 10Carboplatin 7Radiotherapy 6Cetuximab 6Docetaxel 5Surveys and Questionnaires 3Radiotherapy, Intensity-Modulated 3Paclitaxel 3Cyclophosphamide 3fludarabine 2cemiplimab 2atezolizumab 2aldesleukin 2Surgical Procedures, Operative 2Standard of Care 2Radiation 2Nivolumab 2Magnetic Resonance Spectroscopy 2Fluorouracil 2Drug Therapy 2vistusertib 1toripalimab 1sitravatinib 1palbociclib 1osimertinib 1olaparib 1niraparib 1lenvatinib 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × durvalumab × 90 days × Clear all
NCT02664935 2026-04-28

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

University of Birmingham

Phase 2 Completed
423 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡